OLUKOTUN ADEOYE Y

Track

Insider profile

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return 15% 8.2% 15.1%
Success rate 99% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
OLUKOTUN ADEOYE Y's trades of Arrowhead Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-23 2025-12-19
PlS Planned sale
54,293 +0.3%
59.48
US$4,679,612 		54,293 +0.3% 59.48 US$4,679,612
2025-12-23 2025-12-19
PlS Planned sale
59,608 -45.6%
27.79
US$3,359,053 		59,608 -45.6% 27.79 US$3,359,053
2025-12-23 2025-12-19
PlS Planned sale
62,695 -32.7%
59.32
US$4,244,653 		62,695 -32.7% 59.32 US$4,244,653
2025-12-19 2025-12-19
PrS Proposed sale
10,000
67.66
US$676,589 		10,000 67.66 US$676,589
2025-01-27 2025-01-23
PlS Planned sale
959 -2.6%
21.00
US$20,139 		959 -2.6% 21.00 US$20,139
2025-01-23 2025-01-23
PrS Proposed sale
959
20.97
US$20,108 		959 20.97 US$20,108
2024-12-30 2024-12-27
PlS Planned sale
2,850 -7.2%
20.00
US$57,000 		2,850 -7.2% 20.00 US$57,000
2024-12-27 2024-12-27
PrS Proposed sale
2,850
19.99
US$56,968 		2,850 19.99 US$56,968
2023-03-06 2023-03-03
S Sale
11,350 -59.1%
32.65
US$370,578 		11,350 -59.1% 32.65 US$370,578
2022-01-04 2022-01-03
PlS Planned sale
244 -4.7%
66.25
US$16,165 		244 -4.7% 66.25 US$16,165
2022-01-04 2022-01-03
PlS Planned sale
1,916 -26.9%
65.04
US$124,617 		1,916 -26.9% 65.04 US$124,617
2022-01-04 2022-01-03
PlS Planned sale
1,890 -21.0%
64.26
US$121,451 		1,890 -21.0% 64.26 US$121,451
2021-09-14 2021-09-13
S Sale
2,750 -23.4%
63.76
US$175,340 		2,750 -23.4% 63.76 US$175,340
2021-09-14 2021-09-13
PlS Planned sale
2,250 -16.1%
63.76
US$143,460 		2,250 -16.1% 63.76 US$143,460
2020-08-17 2020-08-13
B Purchase
5,350 +inf%
0.94
US$5,029 		5,350 +inf% 0.94 US$5,029